Specifically, research on GHK-incorporated collagen matrices demonstrates that the peptide significantly increases the levels of glutathione (GSH) and ascorbic acid in wound tissues
In contrast, no clastogenicity was noted at a dose of 750 mg/kg/day (1.8-times the MHDD, based on a body surface area comparison), suggesting a threshold effect
Lassman AB, Seplveda-Snchez JM, Cloughesy TF, Gil-Gil MJ, Puduvalli VK, Raizer JJ, et al
Human apolipoprotein E
This mechanism is distinct from GHK-Cus gene modulation and provides more targeted inflammatory pathway control in the KLOW formulation
Our Peptide Therapy allows for treatments that are uniquely you , based on what your needs